ofranergene,Bevacizumab
vbl therapeutics,roche
['ofranergene', 'ovarian']
relapsed refractory ovarian cancer are difficult to treat. negative results for ofranergene obadenovec. we need more efforts to get the right drug for this difficult to treat disease. #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists